未知生产厂商
Ganstigmine is an orally active, geneserine derived, carbamate-based acetylcholinesterase inhibitor developed for the treatment of Alzheimer's disease.
Ganstigmine is an orally active, geneserine derived, carbamate-based acetylcholinesterase inhibitor developed for the treatment of Alzheimer's disease.
Investigated for use/treatment in alzheimer's disease.
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
